Your browser doesn't support javascript.
loading
Cardiovascular disease risk in paediatric and young adult non-alcoholic fatty liver disease.
Simon, Tracey G; Roelstraete, Bjorn; Alkhouri, Naim; Hagström, Hannes; Sundström, Johan; Ludvigsson, Jonas F.
Afiliação
  • Simon TG; Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA tgsimon@mgh.harvard.edu.
  • Roelstraete B; Karolinska Institute, Stockholm, Sweden.
  • Alkhouri N; Hepatology, Arizona Liver Health, Chandler, Arizona, USA.
  • Hagström H; Karolinska Institute, Stockholm, Sweden.
  • Sundström J; Division of Hepatology, Department of Upper GI Diseases, Karolinska Hospital, Stockholm, Sweden.
  • Ludvigsson JF; Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
Gut ; 72(3): 573-580, 2023 03.
Article em En | MEDLINE | ID: mdl-36522149
ABSTRACT

OBJECTIVE:

Longitudinal evidence is lacking regarding the long-term risk of major adverse cardiovascular events (MACE) in children and young adults with non-alcoholic fatty liver disease (NAFLD).

DESIGN:

This nationwide cohort study included all Swedish children and young adults ≤25 years old with histologically confirmed NAFLD and without underlying cardiovascular disease (CVD) at baseline (1966-2016; n=699). NAFLD was defined from prospectively recorded histopathology, and further categorised as simple steatosis or non-alcoholic steatohepatitis (NASH). NAFLD patients were matched to ≤5 population controls without NAFLD or CVD (n=3353). Using Cox proportional hazards modelling, we calculated multivariable-adjusted HRs (aHRs) and 95% CIs for incident MACE (ie, ischaemic heart disease, stroke, congestive heart failure or cardiovascular mortality). In secondary analyses, we also explored rates of incident cardiac arrhythmias.

RESULTS:

Over a median follow-up of 16.6 years, incident MACE was confirmed in 33 NAFLD patients and 52 controls. NAFLD patients had significantly higher rates of MACE than controls (3.1 vs 0.9/1000 person-years (PY); difference=2.1/1000 PY; aHR=2.33, 95% CI=1.43 to 3.78), including higher rates of ischaemic heart disease (difference=1.4/1000 PY; aHR=3.07, 95% CI 1.62 to 5.83) and congestive heart failure (difference=0.5/1000 PY; aHR=3.89, 95% CI=1.20 to 12.64). Rates of incident MACE outcomes appeared to be further augmented with NASH (aHR=5.27, 95% CI=1.96 to 14.19). In secondary analyses, NAFLD patients also had significantly higher rates of cardiac arrythmias (aHR=3.16, 95% CI=1.49 to 6.68).

CONCLUSION:

Compared with matched population controls, children and young adults with biopsy-proven NAFLD had significantly higher rates of incident MACE, including ischaemic heart disease and congestive heart failure. Research to better characterise cardiovascular risk in children and young adults with NAFLD should be prioritised.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Doenças Cardiovasculares / Hepatopatia Gordurosa não Alcoólica / Insuficiência Cardíaca Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Child / Humans Idioma: En Revista: Gut Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Doenças Cardiovasculares / Hepatopatia Gordurosa não Alcoólica / Insuficiência Cardíaca Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Child / Humans Idioma: En Revista: Gut Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos